Emergent BioSolutions | Kısa Vadeli Yükümlülükler



Kısa Vadeli Yükümlülükler Değişiklik Tarih
Acadia Pharmaceuticals USD 356.58M 26.56M 2025-09
Akebia Therapeutics USD 133.38M 14.66M 2025-09
ALKERMES USD 474.36M 31.6M 2025-09
Alnylam Pharmaceuticals USD 1.47B 89.13M 2025-12
Amarin USD 182.23M 3.71M 2025-09
ANI Pharmaceuticals USD 270.56M 33.72M 2025-09
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Coherus Biosciences USD 372.3M 108.67M 2025-09
Exact Sciences USD 584.26M 62.33M 2025-09
Exelixis USD 405.64M 31.86M 2025-12
Glaxosmithkline GBP 28.68B 8.3B 2025-09
Heron Therapeutics USD 89.71M 168.89M 2025-09
Ionis Pharmaceuticals USD 903.46M 6.22M 2025-09
Ironwood Pharmaceuticals USD 242.5M 9.98M 2025-09
Lexicon Pharmaceuticals USD 34.84M 75.86M 2025-06
Lonza CHF 3.58B 970M 2024-12
Merck USD 28.63B 2.59B 2025-09
Moderna USD 1.68B 109M 2025-09
Myriad Genetics USD 148M 51.9M 2025-09
Nektar Therapeutics USD 66.34M 5.05M 2025-09
Neurocrine Biosciences USD 743.4M 105.4M 2025-12
Pacira USD 107.08M 206.09M 2025-09
Pfizer USD 36.6B 1.13B 2025-09
PTC Therapeutics USD 866.24M 238.44M 2025-09
Sanofi EUR 28.35B 3.76B 2025-12
Sarepta Therapeutics USD 921.42M 1.48M 2025-09
United Therapeutics USD 546.3M 19.2M 2025-09
Vanda Pharmaceuticals USD 145.16M 27.29M 2025-12
Xoma USD 28.3M 6.81M 2025-09


Emergent BioSolutions Kısa Vadeli Yükümlülükler - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Feb 2026.